Skip to main content

Table 2 Response for patients treated with pemetrexed plus platinum (n = 53).

From: Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients

Response

N (%)

95% CI (%)

CR

-

-

PR

7(13.2)

5.48 to 25.34

SD

36(67.9)

56.68 to 80.08

PD

10(18.9)

9.44 to 31.97

  1. CI, confidence interval; -, no data.